tirzepatide vs semaglutide for diabetes Subcutaneously administered adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials | Diabetologia Tirzepatide versus Semaglutide Weight Loss

A universal gut-microbiome-derived signature predicts cirrhosis

Diabetes risk reduction: Metformin reduces diabetes progression risk by roughly 31%

Alternatively, using a 20mg vial with 2ml produces a 10mg/ml solution where even 12mg requires only 1.2ml, fitting comfortably in a standard insulin syringe

Individuals interested in supporting digestive wellness, microbiome diversity, and broader metabolic health may consider a daily probiotic as part of a comprehensive wellness plan.

Disruptions to the gut microbiotas composition can have significant repercussions, influencing the development of major diseases (Figure 2)

Semaglutide reduces cardiovascular risk factors, such as waist circumference, blood pressure, and lipids